Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Topline data are expected in second half of 2023. EMBARK will be the first completed randomized study of an IBAT inhibitor for the treatment of biliary atresia. ... | May 11, 2023
Phase 2 trials of VTX958 are ongoing in plaque psoriasis, Crohn’s disease and psoriatic arthritis, with topline data in plaque psoriasis expected in Q4 2023 The Phase 2 trial of VTX002 in... | May 11, 2023
Core business outperforms, delivering 14% topline growth; Customer acquisition strength in March drives full-year guidance higher; Unlevered free cash flow margin of 28% resulting from pricing... | May 9, 2023
WASHINGTON (dpa-AFX) - Novavax, Inc. (NVAX) announced Tuesday positive Phase 2 topline results for COVID-Influenza Combination, standalone influenza, and high-dose COVID vaccine candidates.These
Press Release: Omnix Medical Announces Excellent Topline Data from the Phase I Clinical Trial of its Novel Anti-Infective OMN6 - OMN6 demonstrates safety and tolerability at clinically significant